DiscoverPeerVoice Endocrinology & Metabolic Disorders VideoDavid Cherney, MD, PhD / Abhinav Sharma, MD, PhD - Optimizing Cardio-Kidney Protection in Patients With T2D and CKD: Expert Insights on the Evolving Role of GLP-1 RAs
David Cherney, MD, PhD / Abhinav Sharma, MD, PhD - Optimizing Cardio-Kidney Protection in Patients With T2D and CKD: Expert Insights on the Evolving Role of GLP-1 RAs

David Cherney, MD, PhD / Abhinav Sharma, MD, PhD - Optimizing Cardio-Kidney Protection in Patients With T2D and CKD: Expert Insights on the Evolving Role of GLP-1 RAs

Update: 2025-12-16
Share

Description

Visit https://www.peervoice.com/HPJ860 to view the entire programme with slides. After completing “David Cherney, MD, PhD / Abhinav Sharma, MD, PhD - Optimizing Cardio-Kidney Protection in Patients With T2D and CKD: Expert Insights on the Evolving Role of GLP-1 RAs”, participants will be able to: Examine the pathogenic mechanisms underlying chronic kidney disease (CKD) and type 2 diabetes (T2D), and their relevance to the foundational pillars of cardio-kidney protection; Discuss the latest clinical evidence on glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in providing cardio-kidney protection for patients with CKD and T2D; and Identify strategies to optimize cardio-kidney outcomes in patients with CKD and T2D.
Comments 
loading
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

David Cherney, MD, PhD / Abhinav Sharma, MD, PhD - Optimizing Cardio-Kidney Protection in Patients With T2D and CKD: Expert Insights on the Evolving Role of GLP-1 RAs

David Cherney, MD, PhD / Abhinav Sharma, MD, PhD - Optimizing Cardio-Kidney Protection in Patients With T2D and CKD: Expert Insights on the Evolving Role of GLP-1 RAs

PeerVoice